Insider Trading April 6, 2026

Ambiq Micro General Counsel Disposes of 811 Shares to Cover RSU Taxes; Stock Up 20% in Past Week

Michele Kim Connors sold 811 AMBQ shares on April 2, 2026, to satisfy tax withholding tied to vested restricted stock units

By Caleb Monroe AMBQ
Ambiq Micro General Counsel Disposes of 811 Shares to Cover RSU Taxes; Stock Up 20% in Past Week
AMBQ

Michele Kim Connors, general counsel of Ambiq Micro, completed two stock sales on April 2, 2026, disposing of a total of 811 shares for $21,209 to meet tax obligations associated with previously reported restricted stock units. The trades occurred at prices between $25.55 and $26.68. Ambiq Micro's shares have climbed 20% over the last week and currently trade at $28.28. Recent company results and analyst commentary show improving revenue and EPS trends, and analysts have adjusted price targets while noting robust demand for Ambiq's edge AI products.

Key Points

  • Michele Kim Connors, Ambiq Micro general counsel, sold 811 shares on April 2, 2026, totaling $21,209.
  • Sales executed in two tranches: 660 shares at $25.55 to $26.36 and 151 shares at $26.64 to $26.68; Connors now directly owns 60,554 shares.
  • Ambiq Micro reported Q4 2025 EPS of -$0.32 versus a -$0.40 forecast and revenue of $20.7 million, prompting revised analyst targets and raised revenue guidance driven by demand for edge AI products.

Michele Kim Connors, who serves as general counsel at Ambiq Micro, Inc. (AMBQ), sold 811 shares of the companys common stock on April 2, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The aggregate proceeds from those transactions totaled $21,209.

The share sales were completed in two separate trades. The first transaction comprised 660 shares sold at prices ranging from $25.55 to $26.36. The second transaction covered 151 shares, with sales executed at prices between $26.64 and $26.68. After these dispositions, Connors retains direct ownership of 60,554 Ambiq Micro shares.

Company filings state that the sales were made to satisfy tax withholding obligations that arose when previously reported restricted stock units vested and were settled. The Form 4 identifies the tax-related purpose as the reason for the disposition rather than any other motive.

Market movement since the sale has been notable. Ambiq Micros stock has risen roughly 20 percent over the past week and is currently quoted at $28.28, which is above the price levels at which Connors sold her shares.


Financial results and analyst reaction

Ambiq Micro reported fourth-quarter results for fiscal 2025 that showed improvement in both earnings per share and revenue. The company posted an EPS of -$0.32 for the quarter, outperforming the consensus forecast of -$0.40, a positive surprise of 20 percent. Quarterly revenue reached $20.7 million, a 2 percent increase from the same quarter a year earlier.

Following the earnings release, BofA Securities increased its price target on Ambiq Micro to $35 from $32 while keeping a Neutral rating. BofA noted that Ambiqs fourth-quarter and first-quarter estimated sales surpassed consensus by 9 percent and 16 percent, respectively. Needham also reiterated its Buy rating and maintained a $48.00 price target, pointing to stronger-than-anticipated demand across multiple product lines.

Management raised revenue guidance on the back of this demand, projecting sales to exceed $100 million by 2026. Both BofA and Needham identified demand for Ambiqs edge AI products as a key contributor to the more optimistic outlook for the companys growth trajectory.


Valuation note and balance sheet

An InvestingPro analysis included with company coverage indicates that the stock appears overvalued at current levels. The analysis also highlights that Ambiq Micro holds more cash than debt on its balance sheet. InvestingPro offers a suite of materials and research tools for investors seeking additional detail on the $607 million market cap semiconductor company, including a comprehensive Pro Research Report and supplemental ProTips.

Overall, the Form 4 filing describes a routine tax-related disposition of shares by an insider, set against a backdrop of improving quarterly results, rising analyst targets, and recent upward movement in the stock price.

Risks

  • Stock valuation - InvestingPro analysis flags the shares as appearing overvalued at current prices, which may affect investor expectations in the semiconductor sector.
  • Dependence on demand for edge AI products - Analyst optimism is tied to stronger demand across Ambiqs product lines, introducing uncertainty if that demand weakens.
  • Market volatility - The shares have climbed roughly 20 percent in the past week, which can indicate short-term price volatility impacting holders and potential entrants.

More from Insider Trading

Lipocine Director Purchases 123,000 Shares Amid Mixed Clinical News Apr 6, 2026 Kinder Morgan Vice President Disposes of $203K in Class P Shares Apr 6, 2026 RA Capital Disposes $14.5M of Vor Biopharma Stock Across Early April Trades Apr 6, 2026 Magnetar Financial Disposes of 23,088 Wheeler Real Estate Shares for About $21.5k Apr 6, 2026 Lipocine CEO Mahesh Patel Buys $50,749 of Stock as Company Reports Phase 3 Setback Apr 6, 2026